doi:10.1007/s001150050572

Paper Title

Therapy with the LHRH agonist leuprorelin acetate for paraphilias and sexually aggressive impulsive behavior

Authors

Peer Briken

Keywords

Paraphilia Treatment
Pedophilia
Sexual Sadism
Sexually Aggressive Behavior
LHRH Agonists
Leuprorelin Acetate
Hormonal Therapy
Sexual Impulsivity
Erection Suppression
Ejaculation Reduction
Masturbation Reduction
Deviant Sexual Urges
Sexual Fantasies
Suicide Risk
Cyproterone Acetate
Carcinogenic Effects
Pharmacological Treatment
Endocrine Therapy
Sexual Offender Treatment
Forensic Psychiatry
German-Speaking Countries
Clinical Study
Psychopharmacology
Sexology
Behavioral Therapy
Psychiatric Interventions
Libido Suppression
Sexual Health

Article Type

Original Article

Journal

Der Nervenarzt

Research Impact Tools

DOI

10.1007/s001150050572

Issue

Volume : 71 | Page No : 380–385

Published On

May, 2000

Downloads

FULL PDF

CITATION

COPY LINK

Abstract

To date, there is no published experience in German-speaking countries in the treatment of paraphilias (pedophilia, sadism) and sexually aggressive impulsive behavior with LHRH (lutein-releasing hormone) agonists. In this study, we describe 11 patients who were treated with the LHRH agonist leuprorelin acetate over a period of 12 months. During the treatment period, there were no further sexually aggressive behaviors and, according to the patients, there was a significant reduction in erection, ejaculation, masturbation, sexually deviant urges and fantasies. One patient died by suicide. Overall, LHRH agonists in combination with other therapeutic methods appear to be a promising alternative to cyproterone acetate with its possible carcinogenic effects.